Noncoding RNAs (ncRNAs) are frequently dysregulated in cancer and other diseases and have shown great potential as tissue-based markers for cancer classification and prognostication. ncRNAs are present in membrane-bound vesicles, such as exosomes, in extracellular human body fluids. Since microRNAs and the other ncRNAs circulate in the bloodstream in highly stable extracellular forms, they may be used as blood-based biomarkers. The identification and use of noninvasive biomarkers is a fundamental tool for biomedical research, but optimal and standardized conditions for processing blood samples for RNA measurement remain to be established. In this chapter, we discuss recent discoveries and controversial topics on circulating ncRNAs and prese...
Triple negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer, and is...
Current clinical guidelines emphasize the unmet need for technological innovations to guide physicia...
Biomarkers are quantifiable indicators of disease. These surrogates should be specific, sensitive, p...
Noncoding RNAs (ncRNAs) are frequently dysregulated in cancer and other diseases and have shown grea...
Non-coding RNAs (ncRNAs) participate in regulation of gene expression, and are highly relevant to pa...
Since the discovery of non-coding RNAs (ncRNAs) a new area has emerged in the field of biomarkers. N...
© 2018 Springer Nature Publishing AGPervasive transcription of the human genome is responsible for t...
Cancer biomarkers can be used to determine the molecular status of a tumor or its metastases, which ...
Recent studies suggested that colorectal cancer influences the types and quantity of nucleic acids -...
Noncoding RNAs (ncRNAs), in the form of structural, catalytic or regulatory RNAs, have emerged to be...
Noncoding RNAs are RNA species that do not encode for proteins, and the majority of the human transc...
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controvers...
In 2020, cardiovascular diseases (CVDs) remain a leading cause of mortality and morbidity, contribut...
Currently, the challenges of contemporary oncology are focused mainly on the development of personal...
Continual discoveries on non-coding RNA (ncRNA) have changed the landscape of human genetics and mol...
Triple negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer, and is...
Current clinical guidelines emphasize the unmet need for technological innovations to guide physicia...
Biomarkers are quantifiable indicators of disease. These surrogates should be specific, sensitive, p...
Noncoding RNAs (ncRNAs) are frequently dysregulated in cancer and other diseases and have shown grea...
Non-coding RNAs (ncRNAs) participate in regulation of gene expression, and are highly relevant to pa...
Since the discovery of non-coding RNAs (ncRNAs) a new area has emerged in the field of biomarkers. N...
© 2018 Springer Nature Publishing AGPervasive transcription of the human genome is responsible for t...
Cancer biomarkers can be used to determine the molecular status of a tumor or its metastases, which ...
Recent studies suggested that colorectal cancer influences the types and quantity of nucleic acids -...
Noncoding RNAs (ncRNAs), in the form of structural, catalytic or regulatory RNAs, have emerged to be...
Noncoding RNAs are RNA species that do not encode for proteins, and the majority of the human transc...
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controvers...
In 2020, cardiovascular diseases (CVDs) remain a leading cause of mortality and morbidity, contribut...
Currently, the challenges of contemporary oncology are focused mainly on the development of personal...
Continual discoveries on non-coding RNA (ncRNA) have changed the landscape of human genetics and mol...
Triple negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer, and is...
Current clinical guidelines emphasize the unmet need for technological innovations to guide physicia...
Biomarkers are quantifiable indicators of disease. These surrogates should be specific, sensitive, p...